Peak6 Investments LLC Crispr Therapeutics Ag Put Options Transaction History

Peak6 Investments LLC

13 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	SELL	$51.17 - $68.18 $900,592 - $1.2 Million	-17,600 Reduced 76.19%	5,500 $297,000
Q1 2024 May 14, 2024	BUY	$60.67 - $89.12 $916,117 - $1.35 Million	15,100 Added 188.75%	23,100 $1.57 Million
Q4 2023 Feb 13, 2024	SELL	$38.62 - $72.18 $1.87 Million - $3.49 Million	-48,400 Reduced 85.82%	8,000 $500,000
Q2 2023 Aug 11, 2023	SELL	$43.47 - $67.77 $3.56 Million - $5.56 Million	-82,000 Reduced 59.25%	56,400 $3.17 Million
Q1 2023 May 12, 2023	SELL	$41.0 - $56.12 $9.72 Million - $13.3 Million	-237,100 Reduced 63.14%	138,400 $6.26 Million
Q4 2022 Feb 10, 2023	SELL	$39.19 - $65.67 $293,925 - $492,525	-7,500 Reduced 1.96%	375,500 $15.3 Million
Q3 2022 Nov 14, 2022	BUY	$61.1 - $83.78 $452,140 - $619,972	7,400 Added 1.97%	383,000 $25 Million
Q2 2022 Aug 12, 2022	BUY	$43.23 - $73.83 $1.45 Million - $2.47 Million	33,500 Added 9.79%	375,600 $22.8 Million
Q1 2022 May 13, 2022	BUY	$53.19 - $79.24 $5.16 Million - $7.69 Million	97,100 Added 39.63%	342,100 $21.5 Million
Q4 2021 Feb 11, 2022	BUY	$70.09 - $111.29 $8.03 Million - $12.7 Million	114,500 Added 87.74%	245,000 $18.6 Million
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $2.18 Million - $3.1 Million	19,800 Added 17.89%	130,500 $14.6 Million
Q2 2021 Aug 13, 2021	SELL	$100.84 - $161.89 $3.92 Million - $6.3 Million	-38,900 Reduced 26.0%	110,700 $17.9 Million
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $16.6 Million - $31.4 Million	149,600 New	149,600 $18.2 Million

523

58M

1.73M

1.84M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.87B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.